| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9B | $3.0B | $3.3B | $2.9B | $2.5B | $0.5B | $0.6B | $0.6B |
| Cost of Revenue | $2.4B | $1.8B | $1.9B | $1.8B | $1.5B | $1.2B | $1.3B | — |
| Gross Profit | $1.5B | $1.2B | $1.3B | $1.1B | $0.9B | $0.2B | $0.2B | $0.2B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.8B | $0.6B | $0.7B | $0.6B | $0.5B | $0.4B | $0.5B | $0.5B |
| Operating Income | $0.6B | $0.5B | $0.6B | $0.4B | $0.4B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.7B | $0.3B | $0.6B | $0.4B | $0.3B | $0.0B | $0.0B | $0.1B |
| EPS (Basic) | $4.36 | $2.00 | $3.42 | $2.40 | $1.63 | $0.28 | $0.27 | $0.38 |
| EPS (Diluted) | $4.31 | $1.97 | $3.37 | $2.38 | $1.61 | $0.28 | $0.27 | $0.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.9B | $6.7B | $6.2B | $4.9B | $4.7B | $4.4B | $4.6B | $4.6B |
| Current Assets | $1.6B | $1.4B | $1.3B | $1.2B | $0.9B | $0.8B | $0.8B | $0.8B |
| Cash & Equivalents | — | — | $0.2B | $0.3B | $0.0B | $0.1B | $0.1B | $0.2B |
| Total Liabilities | $3.1B | $3.5B | $3.0B | $2.2B | $2.2B | $2.0B | $2.0B | $1.9B |
| Current Liabilities | $1.0B | $0.8B | $0.7B | $0.6B | $0.6B | $0.5B | $0.5B | $0.5B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.6B | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B |
| Investing Cash Flow | $0.5B | $-0.8B | $-1.2B | $-0.1B | $-0.3B | $-0.1B | $-0.2B | $-0.0B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.0B | $0.1B | $0.5B | $-0.1B | $-0.2B | $-0.3B | $-0.2B | $-0.2B |